MainScienceBiologyBiochemistry and Molecular Biology › AmberGen, Inc.

AmberGen, Inc.

Edit Page
Report
Scan day: 17 February 2014 UTC
11
Virus safety - good
Description: Develops tools for drug discovery and diagnostic assays, using cell-free expression and protein libraries to produce microarrays. Focused on asthma, osteoporosis and Alzheimer's disease, at Boston and Waltham, Massachusetts.
Photocleavable labeling reagents Photocleavable phosphoramidites PC-DNA-peptide hybridization tags Genomic Cancer Signature Discovery A new approach to proteomics and biomarker discovery High-sensitivity mass spec-based mutation scanning
Size: 237 chars

Contact Information

Phone&Fax:
Address:
Extended:

WEBSITE Info

Page title:Ambergen
Keywords:
Description:
IP-address:205.178.152.33

WHOIS Info

NS
Name Server: NS63.WORLDNIC.COM
Name Server: NS64.WORLDNIC.COM
WHOIS
Status: clientTransferProhibited
Date
Creation Date: 18-jul-1997
Expiration Date: 17-jul-2016